KPCM
WST icon

Kings Point Capital Management’s West Pharmaceutical WST Stock Holding History

Kings Point Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$1.06M Hold
2,574
– – 0.09% 101
2021
Q4 		$1.21M Buy
2,574
+11
+0.4% +$4.74K 0.1% 101
2021
Q3 		$1.09M Buy
2,563
+24
+0.9% +$10.1K 0.1% 104
2021
Q2 		$912K Sell
2,539
-50
-2% -$16.5K 0.08% 113
2021
Q1 		$730K Sell
2,589
-33
-1% -$9.44K 0.07% 116
2020
Q4 		$743K Sell
2,622
-173
-6% -$48.5K 0.08% 116
2020
Q3 		$768K Hold
2,795
– – 0.1% 110
2020
Q2 		$635K Hold
2,795
– – 0.09% 109
2020
Q1 		$426K Hold
2,795
– – 0.08% 117
2019
Q4 		$420K Hold
2,795
– – 0.06% 134
2019
Q3 		$396K Sell
2,795
-69
-2% -$9.5K 0.07% 129
2019
Q2 		$358K Buy
2,864
+90
+3% +$10.6K 0.07% 120
2019
Q1 		$306K Hold
2,774
– – 0.06% 119
2018
Q4 		$272K Hold
2,774
– – 0.06% 121
2018
Q3 		$343K Sell
2,774
-5,981
-68% -$671K 0.06% 130
2018
Q2 		$869K Sell
8,755
-165
-2% -$15.2K 0.17% 96
2018
Q1 		$788K Sell
8,920
-1,082
-11% -$101K 0.16% 99
2017
Q4 		$987K Hold
10,002
– – 0.21% 85
2017
Q3 		$963K Sell
10,002
-3,270
-25% -$296K 0.21% 81
2017
Q2 		$1.25M Sell
13,272
-372
-3% -$34.2K 0.29% 78
2017
Q1 		$1.11M Sell
13,644
-56,235
-80% -$4.7M 0.26% 79
2016
Q4 		$5.93M Buy
69,879
+7,490
+12% +$589K 1.46% 29
2016
Q3 		$4.65M Sell
62,389
-321
-0.5% -$25.5K 1.23% 30
2016
Q2 		$4.76M Sell
62,710
-45,655
-42% -$3.32M 1.22% 32
2016
Q1 		$7.51M Buy
108,365
+135
+0.1% +$8.12K 1.91% 19
2015
Q4 		$6.52M Buy
108,230
+1,363
+1% +$82K 1.62% 24
2015
Q3 		$5.78M Buy
106,867
+16,488
+18% +$961K 1.52% 27
2015
Q2 		$5.25M Buy
90,379
+81,879
+963% +$4.57M 1.27% 32
2015
Q1 		$512K Buy
+8,500
New +$453K 0.13% 92

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Kings Point Capital Management's WST Position: Q1 2022 in Review

Kings Point Capital Management held its West Pharmaceutical (WST) position steady in Q1 2022 at 2,574 shares worth $1.06M. The position accounts for 0.09% of the portfolio, ranked #101.

Kings Point Capital Management first reported a position in WST in Q1 2015 and has held it in 29 quarters since. The position peaked at $7.51M in Q1 2016. 717 funds tracked by Wall St. Rank hold WST as of Q1 2022.

  • Kings Point Capital Management held 2,574 shares of West Pharmaceutical worth $1.06M as of Q1 2022.
  • Kings Point Capital Management left its West Pharmaceutical share count unchanged in Q1 2022.
  • West Pharmaceutical made up 0.09% of Kings Point Capital Management's portfolio in Q1 2022, its #101 holding.
  • Kings Point Capital Management first reported a position in West Pharmaceutical in Q1 2015 and has held it in 29 quarters since.
  • Kings Point Capital Management's West Pharmaceutical position peaked at $7.51M in Q1 2016.
  • 717 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2022.

Based on Kings Point Capital Management's 13F filing for Q1 2022, filed 13 May 2022.